Trump order signals shake-up in drug pricing innovation through Medicare and Medicaid

President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs. As part of his first-day executive actions, Trump […]